Clls stock forecast
CLLS Stock Price, Forecast & News (Cellectis) | MarketBeat Analyzing Cellectis (NASDAQ:CLLS) stock? View CLLS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Cellectis S.a. - CLLS - Stock Price Today - Zacks View Cellectis S.A. CLLS investment & stock information. Get the latest Cellectis S.A. CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CLLS Price Target | Cellectis SA Stock Forecast & Ratings See Cellectis SA price target based on 6 analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $25.25 with a high forecast of $39.00 and a low forecast of $11.00. The average price target represents a 207.55% increase from the last price of $8.21.
Buy or Sell CLLS (Cellectis S.A.) stocks (forecast)?
Analyzing Cellectis (NASDAQ:CLLS) stock? View CLLS's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Cellectis S.a. - CLLS - Stock Price Today - Zacks View Cellectis S.A. CLLS investment & stock information. Get the latest Cellectis S.A. CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CLLS Price Target | Cellectis SA Stock Forecast & Ratings See Cellectis SA price target based on 6 analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $25.25 with a high forecast of $39.00 and a low forecast of $11.00. The average price target represents a 207.55% increase from the last price of $8.21. CLLS | Cellectis S.A. ADR Overview | MarketWatch
Oct 05, 2019 · The stock traded up 0.34% over the course of the day. Itamar Medical (OTC: ITMMF) stock hit $0.14 on Friday morning, setting a new 52-week low. …
Cellectis - CLLS - Stock Price & News | The Motley Fool Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. The Ascent is The Motley Fool's new Cellectis S.A. (CLLS) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Cellectis S.A. (CLLS) stock, price quote and chart, trading and investing tools. CLLS | Cellectis S.A. ADR Advanced Charts | MarketWatch All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange
Cellectis S.A. ADR, CLLS Quick Chart - (NAS) CLLS ...
CLLS Stock Price and Chart — NASDAQ:CLLS — TradingView View live CELLECTIS ADS EACH REPR 1 ORD SPON chart to track its stock's price action. Find market predictions, CLLS financials and market news. CLLS -- Is Its Stock Price A Worthy Investment? Learn More. CLLS Stock Summary. With a year-over-year growth in debt of 2,216.27%, Cellectis SA's debt growth rate surpasses 98.43% of about US stocks. In terms of twelve month growth in earnings before interest and taxes, Cellectis SA is reporting a growth rate of 404.86%; that's higher than 96.71% of US stocks. Valero Energy Stock Forecast: up to 70.276 USD! - VLO ... Historical index on US Stock Market : B+ "Should I invest in Valero Energy stock?" "Should I trade "VLO" stock today?" According to our live Forecast System, Valero Energy Corporation stock is an awesome long-term (1-year) investment*. "VLO" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.
7 days ago · Analysts forecast that Cellectis SA (NASDAQ:CLLS) will post earnings of ($0.72) per share for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Cellectis’ earnings. Cellectis posted earnings per share of ($0.36) during the same quarter last year, which indicates a negative year-over-year growth rate of 100%.
Cellectis SA is a biopharmaceutical company that engages in the research and development of genome engineering technology. Its therapeutic products are still in the preclinical stage which is developed for various kinds of tumors. EnLink Midstream, LLC (ENLC) Stock Analysis & News ... Get breaking news and analysis on EnLink Midstream, LLC (ENLC) stock, price quote and chart, trading and investing tools. Cellectis SA Stock Forecast | CLLS Stock Predictions
CLLS: Cellectis S.A. - Price & Consenus Chart - Zacks.com CLLS: Cellectis S.A. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Cellectis S.A. from Zacks Investment Research CLLS Stock Price and Chart — NASDAQ:CLLS — TradingView View live CELLECTIS ADS EACH REPR 1 ORD SPON chart to track its stock's price action. Find market predictions, CLLS financials and market news.